EcoDrugPlus

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSONIG00000020577
Gene Symbol: ADRB2A
1 Cross references
195 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSONIG00000020532
Gene Symbol: ADRB3A
1 Cross references
196 Possible Orthologues:

Aldose Reductase

Ensembl ID : ENSONIG00000016816
Gene Symbol: LOC100701114
3 Cross references
345 Possible Orthologues:

Aldose Reductase

Ensembl ID : ENSONIG00000016805
Gene Symbol: LOC100700843
3 Cross references
343 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSONIG00000017174
Gene Symbol: GAA
1 Cross references
234 Possible Orthologues:

Alpha-1a Adrenergic Receptor

Ensembl ID : ENSONIG00000032296
Gene Symbol: LOC100708890
4 Cross references
202 Possible Orthologues:

Alpha-Synuclein

Ensembl ID : ENSONIG00000014957
Gene Symbol: LOC100691213
3 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSONIG00000011246
Gene Symbol: AOC1
4 Cross references
231 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSONIG00000012154
Gene Symbol: APP
4 Cross references
203 Possible Orthologues:

Amyloid-Beta A4 Protein

Ensembl ID : ENSONIG00000014295
Gene Symbol: LOC100709268
3 Cross references
205 Possible Orthologues:

Androgen Receptor Alpha

Ensembl ID : ENSONIG00000017538
Gene Symbol: ARA
2 Cross references
206 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSONIG00000033827
Gene Symbol: AGTR1
3 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).